Inventor · disambiguated record
Bing Wang
Also filed as: WANG BING · WANG BING C
54 granted patents·42 pending applications·788 citations·filing 2001–2024
98Inventor score
Top patents by PatentIndex Score
96 records- 0196US8012976B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)BIOMARIN PHARM INC·Filed 2009·Granted Sep 6, 2011·40 cites·5 claims
- 0296US6653346B1Cytoprotective benzofuran derivativesGALILEO PHARMACEUTICALS INC·Filed 2003·Granted Nov 25, 2003·91 cites·28 claims
- 0395US8044097B2Chroman derivativesAMPERE LIFE SCIENCES INC·Filed 2009·Granted Oct 25, 2011·39 cites·11 claims
- 0495US7514461B2Chroman derivativesEDISON PHARMACEUTICALS INC·Filed 2004·Granted Apr 7, 2009·59 cites·6 claims
- 0595US7470798B27,8-bicycloalkyl-chroman derivativesEDISON PHARMACEUTICALS INC·Filed 2004·Granted Dec 30, 2008·60 cites·28 claims
- 0695US6900218B2Pyruvate derivativesGALILEO PHARMACEUTICALS INC·Filed 2002·Granted May 31, 2005·47 cites·4 claims
- 0794US7875607B27,8-bicycloakyl-chroman derivativesAMPERE LIFE SCIENCES INC·Filed 2008·Granted Jan 25, 2011·38 cites·7 claims
- 0894US7034054B2Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherolsGALILEO PHARMACEUTICALS INC·Filed 2001·Granted Apr 25, 2006·50 cites·43 claims
- 0993US8791155B2Chroman derivativesWANG BING·Filed 2011·Granted Jul 29, 2014·19 cites·7 claims
- 1093US6608196B2Process for solid supported synthesis of pyruvate-derived compoundsGALILEO PHARMACEUTICALS INC·Filed 2002·Granted Aug 19, 2003·95 cites·22 claims
- 1192US8420650B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)WANG BING·Filed 2011·Granted Apr 16, 2013·15 cites·15 claims
- 1292US7078541B2Benzofuran derivativesGALILEO PHARMACEUTICALS INC·Filed 2003·Granted Jul 18, 2006·42 cites·20 claims
- 1391US8088760B2Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)CHU DANIEL·Filed 2009·Granted Jan 3, 2012·29 cites·25 claims
- 1490US9820985B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)MEDIVATION TECH LLC·Filed 2015·Granted Nov 21, 2017·7 cites·27 claims
- 1590US9139580B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2013·Granted Sep 22, 2015·14 cites·1 claims
- 1689US10336807B2Chimeric proteins and methods of immunotherapyUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Jul 2, 2019·4 cites·16 claims
- 1788US8999987B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)BIOMARIN PHARM INC·Filed 2013·Granted Apr 7, 2015·8 cites·23 claims
- 1888US8735392B2Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate saltWANG BING·Filed 2011·Granted May 27, 2014·15 cites·5 claims
- 1988US8541403B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiencyCHU DANIEL·Filed 2011·Granted Sep 24, 2013·15 cites·38 claims
- 2087US9126993B2Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2014·Granted Sep 8, 2015·9 cites·1 claims
- 2186US9018201B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiencyBIOMARIN PHARM INC·Filed 2013·Granted Apr 28, 2015·8 cites·21 claims
- 2286US8765945B2Processes of synthesizing dihydropyridophthalazinone derivativesWANG BING·Filed 2011·Granted Jul 1, 2014·9 cites·46 claims
- 2385US10189837B2Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate saltMEDIVATION TECH LLC·Filed 2017·Granted Jan 29, 2019·5 cites·6 claims
- 2485US7576094B2Spiro derivatives as lipoxygenase inhibitorsLILLY CO ELI·Filed 2005·Granted Aug 18, 2009·9 cites·37 claims
- 2583US11111287B2Chimeric proteins and methods of immunotherapyUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Sep 7, 2021·1 cites·13 claims
- 2683US9926303B2Processes of synthesizing dihydropyridophthalazinone derivativesMEDIVATION TECH LLC·Filed 2014·Granted Mar 27, 2018·5 cites·1 claims
- 2782US10227312B2Glucosylceramide synthase inhibitors for the treatment of diseasesBIOMARIN PHARM INC·Filed 2016·Granted Mar 12, 2019·2 cites·18 claims
- 2882US8703761B2Organic compoundsFORSTER CORNELIA JUTTA·Filed 2009·Granted Apr 22, 2014·11 cites·14 claims
- 2981US10493078B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP) for use in treatment of diseases associated with a PTEN deficiencyMEDIVATION TECH LLC·Filed 2018·Granted Dec 3, 2019·2 cites·8 claims
- 3081US8680114B2AKT protein kinase inhibitorsMITCHELL IAN S·Filed 2009·Granted Mar 25, 2014·5 cites·20 claims
- 3180US6916850B2Pyruvate derivativesGALILEO PHARMACEUTICALS INC·Filed 2002·Granted Jul 12, 2005·5 cites·60 claims
- 3279US7629375B2Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methodsJOHNSON & JOHNSON CONSUMER·Filed 2004·Granted Dec 8, 2009·9 cites·9 claims
- 3378US10227323B2Glucosylceramide synthase inhibitors for the treatment of diseasesBIOMARIN PHARM INC·Filed 2014·Granted Mar 12, 2019·3 cites·21 claims
- 3476US10780088B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)MEDIVATION TECH LLC·Filed 2019·Granted Sep 22, 2020·0 cites·16 claims
- 3574US11364241B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)MEDIVATION TECH LLC·Filed 2020·Granted Jun 21, 2022·0 cites·16 claims
- 3674US2023416336A1Chimeric proteins and methods of immunotherapyUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 3773US2023079913A1Glycolate oxidase inhibitors for the treatment of diseaseBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 3873US2023089374A1Glycolate oxidase inhibitors for the treatment of diseaseBIOMARIN PHARM INC·Filed 2022·Application pending·0 cites
- 3972US2021261557A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2021·Application pending·0 cites
- 4072US2025051763A1Methods and systems for conditionally regulating gene expressionFUND D ANNA DE SOMMER CHAMPALIMAUD E DR CARLOS MONTEZ CHAMPALIMAUD FOUNDATION·Filed 2023·Application pending·0 cites
- 4171US6667330B2Furanone derivativesGALILEO PHARMACEUTICALS INC·Filed 2003·Granted Dec 23, 2003·6 cites·47 claims
- 4268US7035550B2All-optical, 3R regeneration using the Sagnac and Mach-Zehnder versions of the terahertz optical asymmetric demultiplexer (TOAD)UNIV PRINCETON·Filed 2003·Granted Apr 25, 2006·9 cites·18 claims
- 4368US2025324977A1Engineered bacteria for enhanced crop productionUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 4465US11384055B2Glycolate oxidase inhibitors for the treatment of diseaseBIOMARIN PHARM INC·Filed 2018·Granted Jul 12, 2022·0 cites·14 claims
- 4565US7737179B2Methods for treatment of dermatological conditionsJ & J CONSUMER COMPANIES INC·Filed 2004·Granted Jun 15, 2010·1 cites·4 claims
- 4664US2020048266A1Glucosylceramide synthase inhibitorsGENZYME CORP·Filed 2019·Application pending·0 cites
- 4763US10543209B2Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)MEDIVATION TECH LLC·Filed 2017·Granted Jan 28, 2020·0 cites·2 claims
- 4862US10927092B2Glucosylceramide synthase inhibitors for the treatment of diseasesBIOMARIN PHARM INC·Filed 2019·Granted Feb 23, 2021·0 cites·14 claims
- 4961US11358932B2N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitorsBIOMARIN PHARM INC·Filed 2019·Granted Jun 14, 2022·0 cites·18 claims
- 5061US2010105607A1Novel semi-synthetic glycopeptides as antibacterial agentsLEAD THERAPEUTICS INC·Filed 2009·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bing Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →